A number of firms have modified their ratings and price targets on shares of Globus Medical (NYSE: GMED) recently: 10/19/2017 – Globus Medical was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating. 10/19/2017 – Globus Medical had its price target lowered by analysts at Barclays PLC from $28.00 to $27.00. […]
